Enhancers, Enhancers – from Their Discovery to Today’S Universe of Transcription Enhancers
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Design Principles for Regulator Gene Expression in a Repressible Gene
Design of Repressible Gene Circuits: M.E. Wall et al. 1 Design Principles for Regulator Gene Expression in a Repressible Gene Circuit Michael E. Wall1,2, William S. Hlavacek3* and Michael A. Savageau4+ 1Computer and Computational Sciences Division and 2Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA 3Theoretical Biology and Biophysics Group (T-10), Theoretical Division, Mail Stop K710, Los Alamos National Laboratory, Los Alamos, NM 87545, USA 4Department of Microbiology and Immunology, The University of Michigan Medical School, Ann Arbor, MI 48109-0620, USA +Current address: Department of Biomedical Engineering, One Shields Avenue, University of California, Davis, CA 95616, USA. *Corresponding author Tel.: +1-505 665 1355 Fax: +1-505 665 3493 E-mail address of the corresponding author: [email protected] Design of Repressible Gene Circuits: M.E. Wall et al. 2 Summary We consider the design of a type of repressible gene circuit that is common in bacteria. In this type of circuit, a regulator protein acts to coordinately repress the expression of effector genes when a signal molecule with which it interacts is present. The regulator protein can also independently influence the expression of its own gene, such that regulator gene expression is repressible (like effector genes), constitutive, or inducible. Thus, a signal-directed change in the activity of the regulator protein can result in one of three patterns of coupled regulator and effector gene expression: direct coupling, in which regulator and effector gene expression change in the same direction; uncoupling, in which regulator gene expression remains constant while effector gene expression changes; or inverse coupling, in which regulator and effector gene expression change in opposite directions. -
Controlled Transcription of Regulator Gene Cars by Tet-On Or by a Strong Promoter Confirms Its Role As a Repressor of Carotenoid Biosynthesis in Fusarium Fujikuroi
microorganisms Article Controlled Transcription of Regulator Gene carS by Tet-on or by a Strong Promoter Confirms Its Role as a Repressor of Carotenoid Biosynthesis in Fusarium fujikuroi Julia Marente , Javier Avalos and M. Carmen Limón * Department of Genetics, Faculty of Biology, University of Seville, 41012 Seville, Spain; [email protected] (J.M.); [email protected] (J.A.) * Correspondence: [email protected]; Tel.: +34-954-555-947 Abstract: Carotenoid biosynthesis is a frequent trait in fungi. In the ascomycete Fusarium fujikuroi, the synthesis of the carboxylic xanthophyll neurosporaxanthin (NX) is stimulated by light. However, the mutants of the carS gene, encoding a protein of the RING finger family, accumulate large NX amounts regardless of illumination, indicating the role of CarS as a negative regulator. To confirm CarS function, we used the Tet-on system to control carS expression in this fungus. The system was first set up with a reporter mluc gene, which showed a positive correlation between the inducer doxycycline and luminescence. Once the system was improved, the carS gene was expressed using Tet-on in the wild strain and in a carS mutant. In both cases, increased carS transcription provoked a downregulation of the structural genes of the pathway and albino phenotypes even under light. Similarly, when the carS gene was constitutively overexpressed under the control of a gpdA promoter, total downregulation of the NX pathway was observed. The results confirmed the role of CarS as a repressor of carotenogenesis in F. fujikuroi and revealed that its expression must be regulated in the wild strain to allow appropriate NX biosynthesis in response to illumination. -
Transcriptional Regulation of Cancer Immune Checkpoints: Emerging Strategies for Immunotherapy
Review Transcriptional Regulation of Cancer Immune Checkpoints: Emerging Strategies for Immunotherapy Simran Venkatraman 1 , Jarek Meller 2,3, Suradej Hongeng 4, Rutaiwan Tohtong 1,5,* and Somchai Chutipongtanate 6,7,* 1 Graduate Program in Molecular Medicine, Faculty of Science Joint Program Faculty of Medicine Ramathibodi Hospital, Faculty of Medicine Siriraj Hospital, Faculty of Dentistry, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand; [email protected] 2 Departments of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA; [email protected] 3 Division of Biomedical Informatics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45267, USA 4 Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand; [email protected] 5 Department of Biochemistry, Faculty of Science, Mahidol University, Bangkok 10400, Thailand 6 Pediatric Translational Research Unit, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand 7 Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand * Correspondence: [email protected] (R.T.); [email protected] (S.C.) Received: 30 October 2020; Accepted: 2 December 2020; Published: 4 December 2020 Abstract: The study of immune evasion has gained a well-deserved eminence in cancer research by successfully developing a new class of therapeutics, immune checkpoint inhibitors, such as pembrolizumab and nivolumab, anti-PD-1 antibodies. By aiming at the immune checkpoint blockade (ICB), these new therapeutics have advanced cancer treatment with notable increases in overall survival and tumor remission. -
Regulatory Region of the Heat Shock-Inducible Capr (Lon) Gene: DNA and Protein Sequences
JOURNAL OF BACTERIOLOGY, Apr. 1985, p. 271-275 Vol. 162, No. 1 0021-9193/85/040271-05$02.00/0 Copyright© 1985, American Society for Microbiology Regulatory Region of the Heat Shock-Inducible capR (Lon) Gene: DNA and Protein Sequences RANDALL C. GAYDA,1t PAUL E. STEPHENS,2 RODNEY HEWICK,3; JOYCE M. SCHOEMAKER,2§ WILLIAM J. DREYER,3 AND ALVIN MARKOVITzt. Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois 606371,- Department of Molecular Genetics, Celltech Ltd., Slough SLJ 4DY, Englan~; and Division of Biology, California Institute of Technology, Pasadena, California 911093 Received 22 August 1984/Accepted 4 January 1985 The CapR protein is an ATP hydrolysis-dependent protease as well as a DNA-stimulated ATPase and a nucleic acid-binding PI.'Otein. The sequences of the 5' end of the capR (ion) gene DNA and N-terminal end of the CapR protein were determined. The sequence of DNA that specifies the N-terminal portion of the CapR protein was identified by comparing the amino acid sequence of the CapR protein with the sequence predicted from the DNA. The DNA and protein sequences established that the mature protein is not processed from a precursor form. No sequence corresponding to an SOS box was found in the 5' sequence of DNA. There were sequences that corresponded to a putative -35 and -10 region for RNA polymerase binding. The capR (ion) gene was recently identified as one Qf 17 heat shock genes in Escherichia coli that are positively regulated by the product of the htpR gene. A comparison of the 5' DNA region of the capR gene with that of several other heat shock genes revealed possible consensus sequences. -
Genomic Misconception
1 Genomic Misconception: A fresh look at the biosafety of transgenic and conventional crops. a plea for a process agnostic regulation Klaus Ammann, University of Bern, [email protected] , Neuchâtel, Switzerland December 9, 2012 names. A shorter version has been published in New Biotechnology Ammann, K. (2014), Genomic Misconception: a fresh look at the biosafety of transgenic and conventional crops. A plea for a process agnostic regulation, New Biotechnology, 31, 1, pp. 1-17, http://www.ask-force.org/web/NewBiotech/Ammann-Genomic-Misconception-printed-2014.pdf Abstract: .......................................................................................................................................... 1 1. The scientific basis of the process agnostic regulation ................................................................... 2 2. How the Genomic Misconception was evolving ............................................................................. 4 2.1. How the ‘Genomic Misconception’ was erroneously maintained in the European Regulation and the Cartagena Protocol on Biosafety ....................................................................................... 6 a) Europe, the development of the transatlantic divide with the United States ........................ 6 b) Legislative History of the Cartagena Protocol and its Genomic Misinterpretation of Transgenesis ................................................................................................................................ 8 3. Conclusions ................................................................................................................................... -
Adenovirus-Mediated Gene Transfer of P16INK4/CDKN2 Into Bax-Negative
Cancer Gene Therapy (2002) 9, 641 – 650 D 2002 Nature Publishing Group All rights reserved 0929-1903/02 $25.00 www.nature.com/cgt Adenovirus-mediated gene transfer of P16INK4/CDKN2 into bax-negative colon cancer cells induces apoptosis and tumor regression in vivo Ingo Tamm,1,2 Axel Schumacher,3 Leonid Karawajew,2 Velia Ruppert,2 Wolfgang Arnold,4 Andreas K Nu¨ssler,5 Peter Neuhaus,5 Bernd Do¨rken,1,2 and Gerhard Wolff 2,4 1Department of Hematology and Oncology, Charite´, Campus Virchow, Humboldt University of Berlin, Berlin, Germany; 2Department of Hematology, Oncology and Tumor Immunology, Robert-Ro¨ssle-Klinik, University Medical Center Charite´, Humboldt University of Berlin, Berlin, Germany; 3Department of Cell Biology, Institute of Biology, Humboldt University of Berlin, Berlin, Germany; 4Max Delbru¨ck Center for Molecular Medicine, Berlin, Germany; and 5Department of General, Visceral, and Transplantation Surgery, Charite´, Campus Virchow, Humboldt University of Berlin, Berlin, Germany. The tumor-suppressor gene p16INK4/CDKN2 (p16) is a cyclin-dependent kinase (cdk) inhibitor and important cell cycle regulator. Here, we show that adenovirus-mediated gene transfer of p16 (AdCMV.p16) into colon cancer cells induces uncoupling of S phase and mitosis and subsequently apoptosis. Flow cytometric analysis revealed that cells infected with AdCMV.p16 showed an initial G2-like arrest followed by S phase without intervening mitosis (DNA >4N). Using microscopic analysis, deformed polyploid cells were detectable only in cells infected with AdCMV.p16 but not in control-infected cells. Subsequently, AdCMV.p16-infected polyploid cells underwent apoptosis, as assessed by AnnexinV staining and DNA fragmentation, suggesting that cell cycle dysregulation is upstream of the onset of apoptosis. -
Negative Feedback Through Mrna Provides the Best Control of Gene-Expression Noise
IEEE TRANSACTIONS ON NANOBIOSCIENCE 1 Negative feedback through mRNA provides the best control of gene-expression noise Abhyudai Singh Member, IEEE Abstract—Genetically identical cell populations exposed to the same environment can exhibit considerable cell-to-cell variation in the levels of specific proteins. This variation or expression noise arises from the inherent stochastic nature of biochemical reactions that constitute gene-expression. Negative feedback loops are common motifs in gene networks that reduce expression noise and intercellular variability in protein levels. Using stochastic models of gene expression we here compare different feedback architectures in their ability to reduce stochasticity in protein levels. A mathematically controlled comparison shows that in physiologically relevant parameter regimes, feedback regulation through the mRNA provides the best suppression of expression noise. Consistent with our theoretical results we find negative feedback loops though the mRNA in essential eukaryotic genes, where feedback is mediated via intron-derived microRNAs. Finally, we find that contrary to previous results, protein mediated translational regulation may not always provide significantly better noise suppression than protein mediated transcriptional regulation. Index Terms—Gene-expression noise, negative feedback, noise suppression, microRNAs, linear noise approximation ! Protein 1 INTRODUCTION He inherent probabilistic nature of biochemical re- T actions that constitute gene-expression together with II Translation low copy numbers of mRNAs can lead to large stochastic IV fluctuations in protein levels [1], [2], [3]. Intercellular I variability in protein levels generated by these stochastic mRNA fluctuations is often referred to as gene-expression noise. III Increasing evidence suggests that gene-expression noise Transcription can be detrimental for the functioning of essential and housekeeping proteins whose levels have to be tightly maintained within certain bounds for optimal performance Promoter Gene [4], [5], [6]. -
Steven Henikoff Position
CURRICULUM VITAE: Steven Henikoff Position: Investigator, Howard Hughes Medical Institute Member, Basic Sciences Division Address: Fred Hutchinson Cancer Research Center 1100 Fairview Ave N. Seattle, Washington 98109-1024 Phone (206) 667-4515; FAX (206) 667-5889 E-mail: [email protected] http://blocks.fhcrc.org/~steveh/ Education 1964-68 University of Chicago, Chicago, Illinois. BS in Chemistry. Research on optical properties of biopolymers, Dr. G. Holzwarth, advisor. 1971-77 Harvard University, Cambridge, Massachusetts. PhD in Biochemistry and Molecular Biology. Dr. M. Meselson, advisor. Thesis: RNA from heat induced puff sites in Drosophila. 1977-80 University of Washington, Seattle, Washington. Postdoctoral fellow in Zoology. Research on position-effect variegation in Drosophila, Dr. C. Laird, advisor, Leukemia Society of America fellow. Professional Experience 1981-85 Fred Hutchinson Cancer Research Center, Seattle, Washington. Assistant Member in Basic Sciences. 1981- University of Washington, Seattle. Affiliate Assistant, Associate and Full Professor of Genetics/Genome Sciences. 1985-88 Fred Hutchinson Cancer Research Center, Seattle, Washington. Associate Member in Basic Sciences. 1988- Fred Hutchinson Cancer Research Center, Seattle, Washington. Member in Basic Sciences. 1990- Investigator, Howard Hughes Medical Institute. Current Research Nucleosome dynamics Transcriptional regulation Centromeric chromatin and centromere evolution Epigenomic technologies Honors (since 2000) 2001 Keynote, 13th International Arabidopsis Conference, -
Developmental Biology Using Purified Genes
LASKER~KOSHLAND SPECIAL ACHIEVEMENT ESSAY IN MEDICAL SCIENCE AWARD Developmental biology using purified genes Donald D Brown Some history Control Anucleolate Magnesium From the NIH I went to the Pasteur Institute mutant deficient After three years of college I entered the in Paris to study bacterial gene regulation in University of Chicago Medical School in the 1959, the year after the Lac repressor had been fall of 1952 and discovered biochemistry and discovered. Before leaving Bethesda, by the research. Lloyd Kozloff, a member of the greatest luck I learned about a small research bacteriophage group in the Department of institution in Baltimore that was associated Biochemistry, guided my research. While in at that time with the Johns Hopkins Medical medical school I began searching for a future School called the Department of Embryology of research subject, thinking it should be an the Carnegie Institution of Washington. I con- important medically related problem but unex- tacted Jim Ebert, the director, and arranged an plored by what were then the modern methods advanced postdoctoral fellowship after my year of biochemistry. in Paris. It is hard to imagine two more diverse The field of embryology, newly named research institutions. ‘developmental biology’, caught my attention. The Pasteur Institute was at the forefront of Reproductive biology was barely discussed, biology, involved in the founding of molecular and descriptive embryology was taught in two biology. Every day at lunch Jacques Monod, lectures as a part of gross anatomy. In 1953, I François Jacob and André Lwoff presided attended a biochemistry journal club discus- over an exciting discussion usually augmented Figure 1 Comparison of control (left), anucleolate sion of the Watson-Crick Nature paper describ- by a prominent visitor. -
Steven Henikoff Position
CURRICULUM VITAE: Steven Henikoff Position: Investigator, Howard Hughes Medical Institute Member, Basic Sciences Division Address: Fred Hutchinson Cancer Research Center 1100 Fairview Ave N. Seattle, Washington 98109-1024 Phone (206) 667-4515; FAX (206) 667-5889 E-mail: [email protected] http://research.fhcrc.org/henikoff/en.html Education 1964-68 UniversitY of Chicago, Chicago, Illinois. BS in ChemistrY. Research on optical properties of biopolymers, Dr. G. Holzwarth, advisor. 1971-77 Harvard UniversitY, Cambridge, Massachusetts. PhD in BiochemistrY and Molecular BiologY. Dr. M. Meselson, advisor. Thesis: RNA from heat induced puff sites in Drosophila. 1977-80 UniversitY of Washington, Seattle, Washington. Postdoctoral fellow in Zoology. Research on position-effect variegation in Drosophila, Dr. C. Laird, advisor, Leukemia SocietY of America fellow. Professional Experience 1981-85 Fred Hutchinson Cancer Research Center, Seattle, Washington. Assistant Member in Basic Sciences. 1981- UniversitY of Washington, Seattle. Affiliate Assistant, Associate and Full Professor of Genetics/Genome Sciences. 1985-88 Fred Hutchinson Cancer Research Center, Seattle, Washington. Associate Member in Basic Sciences. 1988- Fred Hutchinson Cancer Research Center, Seattle, Washington. Member in Basic Sciences. 1990- Investigator, Howard Hughes Medical Institute. Current Research Nucleosome dYnamics Transcriptional regulation Centromeric chromatin and centromere evolution Epigenomic technologies Ongoing Funding Howard Hughes Medical Institute Investigator 04/1/1990 -
Stress-Induced Expression of the Escherichia Coli Phage Shock Protein Operon Is D,E P Endent on 0 -54 and Modulated by Positive and Negative Feedback Mechanisms
Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press Stress-induced expression of the Escherichia coli phage shock protein operon is d,e p endent on 0 -54 and modulated by positive and negative feedback mechanisms Lorin Weiner, Janice L. Brissette, 1 and Peter Model z The Rockefeller University, New York, New York 10021 USA The phage shock protein (psp) operon of Escherichia coli is strongly induced in response to heat, ethanol, osmotic shock, and infection by filamentous bacteriophages. The operon contains at least four genes--pspA, pspB, pspC, and pspE--and is regulated at the transcriptional level. We report here that psp expression is controlled by a network of positive and negative regulatory factors and that transcription in response to all inducing agents is directed by the or-factor r s4. Negative regulation is mediated by both PspA and the r heat shock proteins. The PspB and PspC proteins cooperatively activate expression, possibly by antagonizing the PspA-controlled repression. The strength of this activation is determined primarily by the concentration of PspC, whereas PspB enhances but is not absolutely essential for PspC-dependent expression. PspC is predicted to contain a leucine zipper, a motif responsible for the dimerization of many eukaryotic transcriptional activators. PspB and PspC, though not necessary for psp expression during heat shock, are required for the strong psp response to phage infection, osmotic shock, and ethanol treatment. The psp operon thus represents a third category of transcriptional control mechanisms, in addition to the r 32- and erE-dependent systems, for genes induced by heat and other stresses. -
DNA Methylation Patterns and Cancer
restriction/modification system, which brought Werner Arber, Daniel Nathans and Hamilton Smith the 1978 Nobel Prize in Physiology or Medicine, and made restriction enzymes the primary tools of Charles Rodolphe Brupbacher Foundation molecular biology. Four decades have passed since then, but the role of 5-methylcytosine in eukaryotic DNA metabolism is still shrouded in mystery. We know that the sperm methylation pattern is largely The erased after fertilization and that methylation is gradually reintroduced Charles Rodolphe Brupbacher Prize during embryogenesis and differentiation, but the processes that for Cancer Research 2017 regulate the cell type- and tissue-specific methylation patterns remain is awarded to to be elucidated. We have also learned that DNA can be not only methylated, but also demethylated, and that aberrant methylation can lead to disease - including cancer. Again, how these processes are regulated remains to be discovered. However, we have learnt a great Sir Adrian Peter Bird, deal about 5-methylcytosine metabolism during the past three decades and much of our knowledge came from the laboratory of Adrian Bird. PhD Adrian spent his doctoral and postdoctoral time in Max Birnstiel’s for his contributions to our understanding laboratory, first in Edinburgh and then in Zurich, studying the amplification of ribosomal DNA in Xenopus laevis. In this organism, of the role of DNA methylation in genomic rDNA in somatic tissues is highly methylated, while the development and disease extrachromosomal amplicons are unmethylated. When he returned to Edinburgh to establish his own group, Adrian set out to study The President The President of the Foundation of the Scientific Advisory Board the methylation pattern of these loci using the newly-available methylation-sensitive restriction enzymes.